
“I think it’s really important that people keep signing up to these type of trials to push research forward.”
This study is looking at a mobile application (app) for people to report their symptoms and how they are feeling during treatment.
Researchers have developed an app for people having treatment for neuroendocrine tumours.
The purpose of this app is to help people during their treatment. It allows them to report symptoms to their hospital team. And it allows the hospital team to record how people are feeling and if there are any changes in their quality of life following treatment.
You use the mobile application to:
The information in the app is analysed. The healthcare team can see your answers on the system. If necessary, they can message you through the app or contact you via email or phone. The app also provides links to online resources for education and support.
The main aims of the study are to:
The following bullet points are a summary of the entry conditions for this study. Talk to your doctor or the study team if you are unsure about any of these. They will be able to advise you.
Who can take part
You may be able to join this study if all of the following apply. You:
Who can’t take part
You cannot join this study if any of these apply. You:
The study team need 2,000 people to take part.
You download the application from your mobile device app store onto your phone or tablet.
You report your symptoms on the app each day. There are daily alerts to remind you to do this. The length of time that you report these symptoms varies according to which treatment you are having. The study team can tell you more about this.
You also complete 6 quality of life questionnaires. The team may call these PROMs. This stands for patient reported outcome measures. Researchers use PROMs to assess how people are feeling, and how they rate their quality of life. You do these on the app:
You don’t have any extra hospital visits if you take part in this trial.
The researchers don’t think you will have any extra side effects if you take part in this study. However answering questions about any symptoms you may have, could cause you to think more about them.
The information you provide is stored electronically. All the information you provide is . It won’t be possible to identify you in any results from the study.
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Rajaventhan Srirajaskanthan
King’s College Hospital NHS Foundation Trust (KCH)
Imaging Equipment Limited
Neuroendocrine Cancer UK
Freephone 0808 800 4040
“I think it’s really important that people keep signing up to these type of trials to push research forward.”